SOX-2 Antibody (IHC)

SOX-2 is a new type of oncogene, which is not only involved in the early stages of tumorigenesis, but also related to the migration, invasion and metastasis of tumor cells. The expression of SOX-2 is related to the prognosis of tumors such as ovarian cancer, breast cancer, head and neck tumors, lung squamous cell carcinoma, and germ cell tumors. It is reported that the combined application of SOX-2 and P63 can specifically detect more than 90% of lung squamous cell carcinomas; in cervical tissue, the expression of SOX-2 is closely related to HPV infection and is related to the process of cervical hyperplasia.